Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter

IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

See all formats and pricing
More options …
Volume 38, Issue 3


Interferon β1a Therapy Changes Lipoprotein Metabolism in Patients with Multiple Sclerosis

Armando Sena / Rui Pedrosa / Véronique Ferret-Sena / Rita Almeida / Maria Lurdes Andrade / Maria Graça Morais / Rémy Couderc
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2000.030


To assess whether interferon β1a (IFNβ1a) therapy affects plasma lipoprotein metabolism, twelve patients with relapsing-remitting multiple sclerosis (MS) were studied during a two-year follow-up period. High density lipoprotein (Hdl2) cholesterol and the Hdl2/Hdl3 ratio were increased at year 2 and lipoprotein (a) was transitorily increased at year 1, in comparison to baseline levels. Apolipoprotein A-I was lower and apolipoprotein E higher at year 1, only in a subgroup of patients who experienced relapses and/or progressed during therapy. These findings suggest that IFNβ1a treatment is associated with changes in the lipoprotein metabolism. Alterations in this metabolism could be related to the immunomodulatory actions of the drug and the disease activity in multiple sclerosis patients.

About the article

Published Online: 2005-06-01

Published in Print: 2000-03-25

Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 38, Issue 3, Pages 209–213, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2000.030.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Jun Eguchi, Kazuya Miyashita, Isamu Fukamachi, Katsuyuki Nakajima, Masami Murakami, Yuko Kawahara, Toru Yamashita, Yasuyuki Ohta, Koji Abe, Atsuko Nakatsuka, Mai Mino, Satoru Takase, Hiroaki Okazaki, Robert A. Hegele, Michael Ploug, Xuchen Hu, Jun Wada, Stephen G. Young, and Anne P. Beigneux
Journal of Clinical Lipidology, 2018
Véronique Ferret-Sena, Carlos Capela, and Armando Sena
International Journal of Molecular Sciences, 2018, Volume 19, Number 6, Page 1639
Yuko Kawahara, Toru Yamashita, Yasuyuki Ohta, Kota Sato, Keiichiro Tsunoda, Mami Takemoto, Nozomi Hishikawa, Jun Eguchi, and Koji Abe
Journal of the Neurological Sciences, 2017, Volume 373, Page 144
Lindsay Meyers, Chassidy J. Groover, Joshua Douglas, Sangmin Lee, David Brand, Michael C. Levin, and Lidia A. Gardner
Journal of Neuroimmunology, 2014, Volume 277, Number 1-2, Page 176
Bianca Weinstock-Guttman, Robert Zivadinov, Dana Horakova, Eva Havrdova, Jun Qu, Grace Shyh, Elizabeth Lakota, Kerri O'Connor, Darlene Badgett, Miriam Tamaño-Blanco, Michaela Tyblova, Sara Hussein, Niels Bergsland, Laura Willis, Jan Krasensky, Manuela Vaneckova, Zdenek Seidl, and Murali Ramanathan
Journal of Neurology, Neurosurgery & Psychiatry, 2013, Volume 84, Number 11, Page 1186
Elisa Cuadrado-Godia, Elvira Munteis, José Enrique Martínez-Rodríguez, Claustre Pont-Sunyer, Gràcia Cucurella, and Jaume Roquer
Medicina Clínica, 2009, Volume 132, Number 7, Page 259
Danielle Burger and Jean-Michel Dayer
Autoimmunity Reviews, 2002, Volume 1, Number 1-2, Page 111
Annals of the New York Academy of Sciences, 2002, Volume 966, Number 1, Page 464
Helen Tremlett and Joel Oger
Journal of Neurology, 2004, Volume 251, Number 11, Page 1297

Comments (0)

Please log in or register to comment.
Log in